Market Place
Sourcing Support
Confo Therapeutics Publishes First Structure Of Antibody-GPCR Complex
01 Oct 2024 //
BUSINESSWIRE
Confo Therapeutics Raises 60M EUR In Series B For GPCR Therapies
25 Jul 2024 //
BUSINESSWIRE
Confo Secures VLAIO Grant Supporting Drug Discovery in Endocrine and MD
28 Mar 2024 //
BUSINESSWIRE
Confo Therapeutics Appoints Stephen Dowd as Chief Business Officer
12 Sep 2023 //
BUSINESSWIRE
IRLAB publishes interim report for the period January-June 2023
29 Aug 2023 //
ACCESSWIRE
Confo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer Pharma
29 Aug 2023 //
BUSINESSWIRE
Confo Therapeutics Enters into Research Collaboration with AbCellera
15 Jun 2023 //
BUSINESSWIRE
Daiichi Sankyo teams up with Confo on drugs for CNS diseases
31 Mar 2023 //
BUSINESSWIRE
Confo Announces Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554
03 Mar 2023 //
BIOSPACE
Confo Announces Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554
02 Mar 2023 //
BUSINESSWIRE
Confo’s Founder Jan Steyaert Receives Prestigious Gabbay Award
27 Oct 2022 //
BUSINESSWIRE
Confo Announces Presentations on CFTX-1554 Preclinical Profiling
15 Sep 2022 //
BUSINESSWIRE
Confo Tx Awarded EUR 1.7M VLAIO Grant to Expand Application of ConfoBody
28 Jun 2022 //
BUSINESSWIRE
Confo Tx Begins Dosing in Phase 1 Trial of CFTX-1554 for Neuropathic Pain
10 Mar 2022 //
BUSINESSWIRE
Confo Expands Patent Estate for ConfoBody-based GPCR Screening Platform
15 Dec 2021 //
BUSINESSWIRE
Confo inks pact with Regeneron to apply its GPCR drug discovery platform
02 Dec 2021 //
PHARMABIZ
Confo Therapeutics Enters Collaborative Agreement Regeneron
29 Nov 2021 //
BUSINESSWIRE
Confo Therapeutics Establishes Medical Advisory Board
10 Jun 2021 //
BUSINESSWIRE
Confo Therapeutics Awarded EUR 1M VLAIO Grant for Pre-Clinical of CFTX-1554
30 Mar 2021 //
BUSINESSWIRE
Confo Awarded EUR 1M VLAIO Grant for Pre-Clinical Development of CFTX-1554
30 Mar 2021 //
BUSINESSWIRE
Confo Therapeutics Announces Selection of First Product Candidate and Initiation
14 Oct 2020 //
BIOSPACE
Confo Therapeutics Announces Selection of First Product Candidate Pre-Clinical
14 Oct 2020 //
BIOSPACE
Confo Therapeutics Reports Grant of Two Key Patents for ConfoBodies
01 Dec 2019 //
BUSINESS WIRE
Confo Therapeutics, DyNAbind ink drug discovery collaboration
05 Jul 2019 //
PHARMABIZ
Confo Therapeutics and DyNAbind to Collaborate on Drug Discovery
03 Jul 2019 //
CONTRACT PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.